Since 1995, the Eppendorf Award for Young European Investigators, endowed with 20,000 EUR, has honored outstanding achievements in the field of biomedical research in Europe once a year.

The Eppendorf Award for Young European Investigators is presented in collaboration with Nature.

Scientists up to the age of 35 with an advanced degree, who are conducting research in Europe, can apply online from October 1, 2025 to January 15, 2026.

An independent jury chaired by Laura Machesky (University of Cambridge, UK) will select the winner of the Eppendorf Award 2026.

Information about the award, the selection criteria and past winners can be found HERE

About the Eppendorf Award for Young European Investigators

With the Eppendorf Award for Young European Investigators, which was established in 1995, Eppendorf SE honors outstanding work in biomedical research and supports young scientists in Europe up to the age of 35. The Eppendorf Award is presented in partnership with the scientific journal Nature. The Award winner is selected by an independent committee composed of Laura Machesky (University of Cambridge, UK), Richard Benton (Université de Lausanne (UNIL), Switzerland), Matthias Hentze (European Molecular Biology Laboratory (EMBL), Heidelberg, Germany), Madeline Lancaster (MRC Laboratory of Molecular Biology, Cambridge, UK), Ben Lehner (Wellcome Sanger Institute, Cambridge, UK; Center for Genomic Regulation PRBB, Barcelona, Spain), Stefan Raunser (Max-Planck-Institut für Molekulare Physiologie, Dortmund, Germany) and Michael Sixt (Institute of Science and Technology Austria ISTA, Klosterneuburg, Austria).

About the Eppendorf Group

Eppendorf is a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world.

The product portfolio of the business units Liquid Handling & Consumables, Separation & Instrumentation and Bioprocess includes, for example, pipettes, pipette tips, centrifuges, mixers, ultra-freezers and bioreactors for cell and gene research. In addition, Eppendorf offers a wide range of high-quality consumables. In fiscal year 2024, the Eppendorf Group recorded consolidated revenue of €980.3 million and invested €69 million in research and development (R&D).

Eppendorf products are used in academic or industrial research laboratories, such as pharmaceutical, biotech, chemical, and food industries, as well as clinical, environmental, forensic, and industrial laboratories for process analysis, production, and quality assurance.

Since 1945, the Eppendorf Group has been headquartered in Hamburg, Germany, and today operates production and R&D sites in Europe, Asia and North America and has subsidiaries in more than 30 countries. Today, the Group employs around 4,500 people worldwide. They all act in accordance with the purpose of the company's founders: to improve human living conditions.

Recent news from Eppendorf